7 November 2001

Companion Healthcare and Eli Lilly launch Web-based Diabetes Programme

Companion Healthcare, a managed care subsidiary of Blue Cross Blue Shield of South Carolina, has developed an online Diabetes Education
Read More
7 November 2001

DocCheck Partners with Belgium’s PharmaPlanet

DocCheck Medical Services GmbH, the leading European physician verification service has announced an agreement with PharmaPlanet , a subsidiary of
Read More
5 November 2001

Computer Motion Recieves $2m Grant for Telesurgery Training

Computer Motion, Inc., the world’s leading developer of surgical robotic systems, has been awarded a $2m research and development grant
Read More
4 November 2001

FDA Issues 11

The Food and Drug Administration has issued 11 "cyber-letters" to Internet vendors selling unapproved Ciproflaxin to US consumers. "Cyber Letters"
Read More
2 November 2001

Siemens and Microsoft Form .Net Alliance

Siemens Medical Solutions Health Services (SMS) has entered into a strategic alliance with Microsoft Corp., under which the two companies
Read More
31 October 2001

“Millstone of History” Holds Back UK E-Health

The UK health service is still struggling to adopt the information technology and business practices that will drag it out
Read More
30 October 2001

Healthcare at Home Chooses Ascent Relationship Management

UK high-tech homecare provider, Healthcare at Home Ltd, has chosen Ascent relationship management (RM), supplied by Ascent Technology, to provide
Read More
26 October 2001

NHS Hits Practice E-mail Connectivity Target

The NHSIA has released the latest figures on levels of connection to NHSnet indicating that the national target to ensure
Read More
25 October 2001

GSK Signs With eSubstance

GlaxoSmithKline has signed up with eSubstance, a London-based content solutions provider, to reorganise the company’s content and unlock the value
Read More
25 October 2001

e-Detailing Moves into Mainstream

Faced with spiralling marketing costs, reduced product lifecycles, and an increasing reliance on "blockbuster" drug launches, pharmaceutical companies are turning
Read More